These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8478710)

  • 1. In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy.
    Higashi K; Clavo AC; Wahl RL
    J Nucl Med; 1993 May; 34(5):773-9. PubMed ID: 8478710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hyperglycemia on in vitro tumor uptake of tritiated FDG, thymidine, L-methionine and L-leucine.
    Torizuka T; Clavo AC; Wahl RL
    J Nucl Med; 1997 Mar; 38(3):382-6. PubMed ID: 9074524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hypoxia on the uptake of tritiated thymidine, L-leucine, L-methionine and FDG in cultured cancer cells.
    Clavo AC; Wahl RL
    J Nucl Med; 1996 Mar; 37(3):502-6. PubMed ID: 8772656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro assessment of FDG, methionine and thymidine uptake.
    Frank A; Gupta N
    J Nucl Med; 1993 Dec; 34(12):2278-80. PubMed ID: 8254426
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine.
    Reinhardt MJ; Kubota K; Yamada S; Iwata R; Yaegashi H
    J Nucl Med; 1997 Feb; 38(2):280-7. PubMed ID: 9025756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell spheroids as a model for evaluation of metabolic changes after irradiation.
    Senekowitsch-Schmidtke R; Matzen K; Truckenbrodt R; Mattes J; Heiss P; Schwaiger M
    J Nucl Med; 1998 Oct; 39(10):1762-8. PubMed ID: 9776284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake.
    Higashi K; Clavo AC; Wahl RL
    J Nucl Med; 1993 Mar; 34(3):414-9. PubMed ID: 8441032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of alpha-aminoisobutyric acid, L-methionine, thymidine and 2-fluoro-2-deoxy-D-glucose to monitor effects of chemotherapy in a human colon carcinoma cell line.
    Schaider H; Haberkorn U; Berger MR; Oberdorfer F; Morr I; van Kaick G
    Eur J Nucl Med; 1996 Jan; 23(1):55-60. PubMed ID: 8586103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine.
    Haberkorn U; Bellemann ME; Altmann A; Gerlach L; Morr I; Oberdorfer F; Brix G; Doll J; Blatter J; van Kaick G
    J Nucl Med; 1997 Aug; 38(8):1215-21. PubMed ID: 9255154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of tritiated thymidine, deoxyglucose and methionine in three lung cancer cell lines: deoxyglucose uptake mirrors tritiated thymidine uptake.
    Nerini-Molteni S; Seregni E; Crippa F; Maffioli L; Botti C; Bombardieri E
    Tumour Biol; 2001; 22(2):92-6. PubMed ID: 11125281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-[methyl-14C]methionine, [6-3H]thymidine, and gallium-67.
    Kubota K; Ishiwata K; Kubota R; Yamada S; Tada M; Sato T; Ido T
    J Nucl Med; 1991 Nov; 32(11):2118-23. PubMed ID: 1834814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor diagnosis by PET: potential of seven tracers examined in five experimental tumors including an artificial metastasis model.
    Ishiwata K; Takahashi T; Iwata R; Tomura M; Tada M; Itoh J; Kameyama M; Ido T
    Int J Rad Appl Instrum B; 1992 Aug; 19(6):611-8. PubMed ID: 1387872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of positron emission tomography tracers in experimental bacterial infections: a comparative biodistribution study of radiolabeled FDG, thymidine, L-methionine, 67Ga-citrate, and 125I-HSA.
    Sugawara Y; Gutowski TD; Fisher SJ; Brown RS; Wahl RL
    Eur J Nucl Med; 1999 Apr; 26(4):333-41. PubMed ID: 10199938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck.
    Minn H; Clavo AC; Grénman R; Wahl RL
    J Nucl Med; 1995 Feb; 36(2):252-8. PubMed ID: 7830126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study.
    Leskinen-Kallio S; Ruotsalainen U; Någren K; Teräs M; Joensuu H
    J Nucl Med; 1991 Jun; 32(6):1211-8. PubMed ID: 2045935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG.
    Kubota R; Kubota K; Yamada S; Tada M; Takahashi T; Iwata R; Tamahashi N
    J Nucl Med; 1995 Mar; 36(3):484-92. PubMed ID: 7884515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of hypoxia on tracer accumulation in squamous-cell carcinoma: in vitro evaluation for PET imaging.
    Minn H; Clavo AC; Wahl RL
    Nucl Med Biol; 1996 Nov; 23(8):941-6. PubMed ID: 9004282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer.
    Lindholm P; Leskinen-Kallio S; Minn H; Bergman J; Haaparanta M; Lehikoinen P; Någren K; Ruotsalainen U; Teräs M; Joensuu H
    J Nucl Med; 1993 Oct; 34(10):1711-6. PubMed ID: 8410288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative double-tracer whole-body autoradiography: uptake of 11C-, 18F- and 3H-labeled compounds in rat tumors.
    d'Argy R; Paul R; Frankenberg L; Stålnacke CG; Lundqvist H; Kangas L; Halldin C; Någren K; Roeda D; Haaparanta M
    Int J Rad Appl Instrum B; 1988; 15(5):577-85. PubMed ID: 2978293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG-PET evaluation of therapeutic effects on VX2 liver tumor.
    Oya N; Nagata Y; Tamaki N; Takagi T; Murata R; Magata Y; Abe M; Konishi J
    J Nucl Med; 1996 Feb; 37(2):296-302. PubMed ID: 8667065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.